RPL7P12: A Drug Target / Disease Biomarker (G100131085)

Target Name: RPL7P12

NCBI ID: G100131085

RPL7P12

Other Name(s): Ribosomal protein L7 pseudogene 12 | ribosomal protein L7 pseudogene 12 | RPL7_3_208

RPL7P12: A Drug Target / Disease Biomarker

RPL7P12 is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique feature is that it is a doublecortin gene, which means it contains two copies of the gene in each cell.

The RPL7P12 gene is located on chromosome 12 and has been shown to play a role in the development and progression of various diseases. Studies have shown that individuals with certain genetic variations in the RPL7P12 gene are at an increased risk of developing certain diseases, such as cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key features of RPL7P12 is its expression in various tissues and cells. Studies have shown that RPL7P12 is expressed in various tissues, including the brain, spinal cord, and peripheral tissues. It is also shown to be involved in the development and progression of various diseases, which suggests that it may be a valuable drug target or biomarker.

Another important feature of RPL7P12 is its role in the regulation of cellular processes. Studies have shown that RPL7P12 is involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis. It is also shown to be involved in the regulation of inflammation, which suggests that it may have potential as a therapeutic target for various diseases.

In addition to its potential drug target or biomarker properties, RPL7P12 is also of interest due to its unique genetic structure. The doublecortin gene has not been seen before, and its function and regulation are not yet fully understood. Understanding the function and regulation of RPL7P12 may have important implications for the development of new treatments for various diseases.

Overall, RPL7P12 is a promising drug target or biomarker due to its unique genetic structure and its involvement in the regulation of various cellular processes. Further research is needed to fully understand its function and potential as a therapeutic target.

Protein Name: Ribosomal Protein L7 Pseudogene 12

The "RPL7P12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL7P12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.tech.

More Common Targets